Myelodysplastic Syndrome in a Case of New-onset Pancytopenia
Largo Medical Center
myelodysplastic syndrome, pancytopenia, piperacillin/tazobactam‐induced immune response, vaccine‐associated pancytopenia
Hemic and Lymphatic Diseases | Internal Medicine
Myelodysplastic syndrome (MDS) is an infrequent cause of pancytopenia, which is a decrease in all three peripheral blood cell lines. We report the case of new-onset pancytopenia following administration of a COVID-19 vaccine and recurrent Zosyn use who was later found to have myelodysplastic syndrome.
Publisher or Conference
Clinical Case Reports
Lancaster I, Patel D, Sethi V, Connelly W, Namey J. Myelodysplastic syndrome in a case of new-onset pancytopenia. Clin Case Rep. 2022;10(3):e05533. doi:10.1002/ccr3.5533